L
LSL Pharma Group Inc
XTSX:LSL
LSL Pharma Group Inc
XTSX:LSL
Price:
0.39
CAD
-2.5%
Market Closed
Market Cap:
CA$49.4m
Relative Value
The Relative Value of one LSL stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.39 CAD, LSL Pharma Group Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LSL Relative Value
HIDDEN
Multiples Across Competitors
LSL Competitors Multiples
LSL Pharma Group Inc Competitors
LSL Pharma Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
L
|
LSL Pharma Group Inc
XTSX:LSL
|
47.3m CAD | 1.8 | 17 | 17.6 | 43 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
224.3B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.2B ZAR | 5.6 | 10.4 | 14.2 | 14.2 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.9B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
39.7B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.4B EUR | 1 | 164.3 | 29.8 | 62.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.5B USD | 12.7 | -2 797.3 | -3 668.8 | -589.5 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
28.4B ZAR | 5.3 | 6.6 | 17 | 17 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
27.7B ZAR | 4.6 | 10.3 | 12.2 | 12.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
